Roy C. Hardiman
CIK 1506218 · Chief Business & Strategy Ofcr · last filed 2026-01-28
Roy C. Hardiman is a Chief Business & Strategy Ofcr who has filed 20 SEC Form 4 insider transactions across 2 companies since 2019. The most recent filing, for ALMS, was dated Jan 28, 2026. Across all open-market trades the lifetime net is −$1.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $5.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$5.14M
2
20
-$1.30M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ALMS | Chief Business & Strategy Ofcr | 212,818 | $24.15 | $5.14M | $0 | 4 | 2026-01-28 |
| Principia Biopharma Inc. (PRNB) Delisted | Chief Business Officer | 0 | — | — | -$1.30M | 7 | 2020-09-28 |
Recent Filings
20 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-28 | ALMS | Grant (A) | — | $0 | EDGAR |
| 2025-07-31 | ALMS | Grant (A) | +28,000 | $0 | EDGAR |
| 2025-02-20 | ALMS | Grant (A) | — | $0 | EDGAR |
| 2024-07-01 | ALMS | Mixed | — | $0 | EDGAR |
| 2020-09-28 | Principia Biopharma Inc. (PRNB) Delisted | Mixed | −119,677 | -$11.97M | EDGAR |
| 2020-09-22 | Principia Biopharma Inc. (PRNB) Delisted | Mixed | — | -$470.6K | EDGAR |
| 2020-06-15 | Principia Biopharma Inc. (PRNB) Delisted | Mixed | — | -$282.2K | EDGAR |
| 2020-03-17 | Principia Biopharma Inc. (PRNB) Delisted | Mixed | — | -$219.2K | EDGAR |
| 2020-03-05 | Principia Biopharma Inc. (PRNB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-12-13 | Principia Biopharma Inc. (PRNB) Delisted | Mixed | — | -$222.3K | EDGAR |